GarcÃa-GarcÃa, J.A.; Pérez-Quintana, M.; Ramos-Giráldez, C.; Cebrián-González, I.; MartÃn-Ponce, M.L.; del Valle-Villagrán, J.; Navarro-Puerto, M.A.; Sánchez-Villegas, J.; Gómez-Herreros, R.; Manoja-Bustos, I.;
et al. Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19. J. Clin. Med. 2021, 10, 4019.
https://doi.org/10.3390/jcm10174019
AMA Style
GarcÃa-GarcÃa JA, Pérez-Quintana M, Ramos-Giráldez C, Cebrián-González I, MartÃn-Ponce ML, del Valle-Villagrán J, Navarro-Puerto MA, Sánchez-Villegas J, Gómez-Herreros R, Manoja-Bustos I,
et al. Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19. Journal of Clinical Medicine. 2021; 10(17):4019.
https://doi.org/10.3390/jcm10174019
Chicago/Turabian Style
GarcÃa-GarcÃa, José A, Marta Pérez-Quintana, Consuelo Ramos-Giráldez, Isabel Cebrián-González, MarÃa L MartÃn-Ponce, José del Valle-Villagrán, MarÃa A Navarro-Puerto, Jorge Sánchez-Villegas, RocÃo Gómez-Herreros, Isabel Manoja-Bustos,
and et al. 2021. "Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19" Journal of Clinical Medicine 10, no. 17: 4019.
https://doi.org/10.3390/jcm10174019
APA Style
GarcÃa-GarcÃa, J. A., Pérez-Quintana, M., Ramos-Giráldez, C., Cebrián-González, I., MartÃn-Ponce, M. L., del Valle-Villagrán, J., Navarro-Puerto, M. A., Sánchez-Villegas, J., Gómez-Herreros, R., Manoja-Bustos, I., León-MartÃ, D., Serrano-RodrÃguez, L., de Miguel-Albarreal, A., Velasco-Romero, M. J., Mula-Falcón, F., Fernández-Pérez, P., Melguizo-Moya, I., Pérez-Quintana, M. J., Romero-Molina, G.,
... Mira-Escarti, J. A.
(2021). Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19. Journal of Clinical Medicine, 10(17), 4019.
https://doi.org/10.3390/jcm10174019